NYSE:KEYS - Keysight Stock Price, Price Target & More

Keysight trades on the New York Stock Exchange (NYSE) under the ticker symbol "KEYS."

Keysight declared that its Board of Directors has approved a share repurchase plan on Wednesday, March 7th 2018, which permits the company to repurchase $350,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to reacquire shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued.

Keysight (NYSE:KEYS) released its quarterly earnings data on Thursday, March, 1st. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.32 by $0.19. The scientific and technical instruments company had revenue of $837 million for the quarter, compared to analysts' expectations of $805.96 million. Keysight had a net margin of 2.64% and a return on equity of 18.19%. The company's revenue for the quarter was up 15.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.57 EPS. View Keysight's Earnings History.

Keysight is scheduled to release their next quarterly earnings announcement on Wednesday, May, 30th 2018. View Earnings Estimates for Keysight.

Keysight issued an update on its second quarter earnings guidance on Thursday, March, 1st. The company provided earnings per share (EPS) guidance of $0.81 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.91. The company issued revenue guidance of $964 million, compared to the consensus revenue estimate of $970.87 million.

10 Wall Street analysts have issued 12 month price objectives for Keysight's shares. Their predictions range from $38.00 to $65.00. On average, they anticipate Keysight's stock price to reach $55.1111 in the next twelve months. View Analyst Ratings for Keysight.

Some companies that are related to Keysight include Roper Technologies (ROP), Fortive (FTV), Sensata Technologies (ST), Cognex (CGNX), MKS Instruments (MKSI), Orbotech (ORBK), Esterline (ESL), Rudolph Technologies (RTEC), Mesa Laboratories (MLAB), Hurco Companies (HURC), Universal Detection Technology (UNDT), Clearsign Combustion (CLIR), International Isotopes (INIS), Sypris Solutions (SYPR) and Elbit Vision Systems (EVSNF).

News coverage about KEYS stock has been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. The research firm rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Keysight earned a daily sentiment score of 0.10 on Accern's scale. They also gave news coverage about the scientific and technical instruments company an impact score of 46.73 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

Keysight's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.57%), American Century Companies Inc. (3.49%), JPMorgan Chase & Co. (2.83%), Victory Capital Management Inc. (2.17%), Sound Shore Management Inc. CT (1.67%) and Wedge Capital Management L L P NC (1.14%). Company insiders that own Keysight stock include Charles J Dockendorff, Ingrid A Estrada, Jay Alexander, John C Skinner, Mark Adam Wallace, Mark Pierpoint, Michael Gasparian, Neil Dougherty, Ronald S Nersesian, Satish Dhanasekaran, Soon Chai Gooi and Stephen D Williams. View Institutional Ownership Trends for Keysight.

KEYS stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., American Century Companies Inc., Sound Shore Management Inc. CT, Diamond Hill Capital Management Inc., Victory Capital Management Inc., Wedge Capital Management L L P NC, Wells Fargo & Company MN and Dimensional Fund Advisors LP. Company insiders that have sold Keysight company stock in the last year include Ingrid A Estrada, Jay Alexander, John C Skinner, Mark Adam Wallace, Mark Pierpoint, Michael Gasparian, Neil Dougherty, Ronald S Nersesian, Satish Dhanasekaran, Soon Chai Gooi and Stephen D Williams. View Insider Buying and Selling for Keysight.

KEYS stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Lord Abbett & CO. LLC, Millennium Management LLC, Loomis Sayles & Co. L P, Thrivent Financial for Lutherans, Columbus Circle Investors, Allianz Asset Management GmbH and Allianz Asset Management GmbH. View Insider Buying and Selling for Keysight.

Shares of KEYS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of KEYS stock can currently be purchased for approximately $53.30.

Keysight has a market capitalization of $10.15 billion and generates $3.19 billion in revenue each year. The scientific and technical instruments company earns $102 million in net income (profit) each year or $2.23 on an earnings per share basis. Keysight employs 12,600 workers across the globe.

Keysight's mailing address is 1400 FOUNTAINGROVE PARKWAY, SANTA ROSA CA, 95403. The scientific and technical instruments company can be reached via phone at 800-829-4444 or via email at [email protected]